Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

68
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
68
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

37
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
37
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

52
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
52
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

51
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
51
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

67
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
67
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

81
A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...
81

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bleeding risk assessment in patients with new-onset atrial fibrillation after CABG.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Integrative analysis of left ventricle and epicardial adipose tissue identifies SDHA and OGDH as candidate targets for ischemic heart disease.

iScience·2026
Same author

Bleeding risk assessment in patients with new-onset atrial fibrillation after coronary surgery: A proof-of-concept study.

European heart journal. Cardiovascular pharmacotherapy·2026
Same author

Long-term survival after percutaneous coronary intervention or coronary artery bypass grafting in patients with diabetes and multivessel disease.

The Journal of thoracic and cardiovascular surgery·2026
Same author

Infections after high-voltage cardiac implantable electronic device replacements.

Heart rhythm O2·2026
Same author

Outcomes of No-Touch Vs Conventionally Harvested Saphenous Veins for Coronary Artery Bypass Surgery: Individual Patient Data Meta-Analysis Protocol.

CJC open·2026

Related Experiment Video

Updated: Oct 12, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K

Life Expectancy After Surgical Aortic Valve Replacement.

Andreas Martinsson1, Susanne J Nielsen2, Milan Milojevic3

  • 1Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Molecular and Clinical Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.

Journal of the American College of Cardiology
|November 26, 2021
PubMed
Summary
This summary is machine-generated.

Surgical aortic valve replacement (SAVR) offers substantial survival, particularly for younger, low-risk patients. Life expectancy varies significantly with age and risk, crucial for Heart Team decisions.

Keywords:
aortic stenosisaortic valve replacementepidemiologyvalvular heart disease

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K

Related Experiment Videos

Last Updated: Oct 12, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
14:14

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

14.2K
Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.5K
Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.9K

Area of Science:

  • Cardiovascular Surgery
  • Interventional Cardiology
  • Biomaterials Science

Background:

  • Choice between surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation depends on surgical risk, age, life expectancy, and valve durability.
  • Current life expectancy data post-SAVR, considering surgical risk and age, remains largely unknown.

Purpose of the Study:

  • To determine the median survival time in patients undergoing SAVR.
  • To analyze survival in relation to surgical risk and chronological age.

Main Methods:

  • Retrospective analysis of 8,353 patients (≥60 years) undergoing isolated SAVR with a bioprosthesis.
  • Risk stratification into low, intermediate, and high using logistic EuroSCORE or EuroSCORE II.
  • Survival estimation using Kaplan-Meier curves and Cox regression analysis for age impact.

Main Results:

  • Median survival: 10.9 years (low-risk), 7.3 years (intermediate-risk), 5.8 years (high-risk).
  • 5-year mortality: 16.5% (low-risk), 30.7% (intermediate-risk), 43.0% (high-risk).
  • In low-risk patients, median survival decreased from 16.2 years (60-64 years) to 6.1 years (≥85 years); age impacted mortality only in this group.

Conclusions:

  • 85% of SAVR patients with bioprostheses are classified as low-risk.
  • Substantial survival is estimated post-SAVR, especially for younger, low-risk individuals.
  • Findings should inform Heart Team discussions regarding treatment choices.